DK0695173T3 - Fremstilling af matricer - Google Patents

Fremstilling af matricer

Info

Publication number
DK0695173T3
DK0695173T3 DK94913238T DK94913238T DK0695173T3 DK 0695173 T3 DK0695173 T3 DK 0695173T3 DK 94913238 T DK94913238 T DK 94913238T DK 94913238 T DK94913238 T DK 94913238T DK 0695173 T3 DK0695173 T3 DK 0695173T3
Authority
DK
Denmark
Prior art keywords
pct
cellulose
matrices
date oct
sec
Prior art date
Application number
DK94913238T
Other languages
Danish (da)
English (en)
Inventor
Seth Bjirk
Gert Ragnarsson
Ragnar Ek
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of DK0695173T3 publication Critical patent/DK0695173T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/05—Elimination by evaporation or heat degradation of a liquid phase
    • C08J2201/0504—Elimination by evaporation or heat degradation of a liquid phase the liquid phase being aqueous
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Polymerisation Methods In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Vending Machines For Individual Products (AREA)
  • Glass Compositions (AREA)
DK94913238T 1993-04-14 1994-04-14 Fremstilling af matricer DK0695173T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301220A SE9301220D0 (sv) 1993-04-14 1993-04-14 Manufacturing matrices
PCT/SE1994/000331 WO1994023703A1 (fr) 1993-04-14 1994-04-14 Fabrication de matrices

Publications (1)

Publication Number Publication Date
DK0695173T3 true DK0695173T3 (da) 2000-07-10

Family

ID=20389559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94913238T DK0695173T3 (da) 1993-04-14 1994-04-14 Fremstilling af matricer

Country Status (16)

Country Link
US (1) US5804217A (fr)
EP (1) EP0695173B1 (fr)
JP (1) JP3385369B2 (fr)
AT (1) ATE189120T1 (fr)
AU (1) AU680494B2 (fr)
CA (1) CA2159908C (fr)
DE (1) DE69422806T2 (fr)
DK (1) DK0695173T3 (fr)
ES (1) ES2144517T3 (fr)
FI (1) FI115442B (fr)
GR (1) GR3033274T3 (fr)
NO (1) NO312085B1 (fr)
NZ (1) NZ265131A (fr)
PT (1) PT695173E (fr)
SE (1) SE9301220D0 (fr)
WO (1) WO1994023703A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941069A1 (fr) * 1996-11-12 1999-09-15 Pharmacia & Upjohn Aktiebolag Element compact compose d'une pluralite de matrices poreuses en cellulose (pcm), son procede de fabrication et d'utilisation
EP0955332B1 (fr) * 1997-01-07 2006-07-19 Kaneka Corporation Agent adsorbant de purification de fluides corporels
EP1137403B1 (fr) 1998-12-11 2009-03-11 Nostrum Pharmaceuticals, Inc. Comprime a liberation prolongee contenant un hydrocolloide et un ether de cellulose
US6572887B2 (en) * 2000-05-01 2003-06-03 National Starch And Chemical Investment Holding Corporation Polysaccharide material for direct compression
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
WO2006115198A1 (fr) * 2005-04-22 2006-11-02 Asahi Kasei Chemicals Corporation Agregat de cellulose poreuse et composition de moulage correspondante
US9132195B2 (en) 2008-05-21 2015-09-15 Asahi Kasei Chemicals Corporation Cellulose powder having excellent segregation preventive effect, and compositions thereof
ES2796835T3 (es) * 2013-03-13 2020-11-30 Intervet Int Bv Sustancias bioactivas estables y métodos de fabricación
JP6522396B2 (ja) * 2015-04-02 2019-05-29 北越コーポレーション株式会社 セルロース多孔質体の製造方法
AU2019101024A4 (en) * 2018-12-24 2019-10-10 Thomas W Railsback Improved cooling apparatus

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286829A (fr) * 1961-12-29
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
CS172640B1 (fr) * 1974-05-30 1977-01-28
SE434848B (sv) * 1976-04-22 1984-08-20 Purdue Research Foundation Forfaringssett for framstellning av porosa cellulosaperlor
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4269859A (en) * 1979-04-19 1981-05-26 Brown Company Cellulose floc granules and process
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4464224A (en) * 1982-06-30 1984-08-07 Cip Inc. Process for manufacture of high bulk paper
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JPS6443530A (en) * 1987-08-10 1989-02-15 Asahi Chemical Ind Porous cellulose particle and its production
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates
SE9002017D0 (sv) * 1990-06-06 1990-06-06 Kabivitrum Ab Process for manufacture of matrices
DE69008526T2 (de) * 1990-07-02 1994-08-18 Bend Res Inc Asymmetrische mikroporöse Kügelchen für regulierbare Freigabe.
ES2075403T3 (es) * 1990-08-24 1995-10-01 Spirig Ag Pharmazeutische Prap Procedimiento para la fabricacion de pellets.
NZ239802A (en) * 1990-09-21 1993-09-27 Merrell Dow Pharma A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
US5223090A (en) * 1991-03-06 1993-06-29 The United States Of America As Represented By The Secretary Of Agriculture Method for fiber loading a chemical compound
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형

Also Published As

Publication number Publication date
GR3033274T3 (en) 2000-09-29
DE69422806T2 (de) 2000-08-17
WO1994023703A1 (fr) 1994-10-27
ATE189120T1 (de) 2000-02-15
AU6547394A (en) 1994-11-08
FI954883A (fi) 1995-10-13
EP0695173A1 (fr) 1996-02-07
NO312085B1 (no) 2002-03-18
PT695173E (pt) 2000-07-31
NO954079L (no) 1995-10-13
JP3385369B2 (ja) 2003-03-10
CA2159908C (fr) 2003-12-30
US5804217A (en) 1998-09-08
SE9301220D0 (sv) 1993-04-14
CA2159908A1 (fr) 1994-10-27
NO954079D0 (no) 1995-10-13
NZ265131A (en) 1998-05-27
DE69422806D1 (de) 2000-03-02
ES2144517T3 (es) 2000-06-16
AU680494B2 (en) 1997-07-31
FI115442B (fi) 2005-05-13
FI954883A0 (fi) 1995-10-13
EP0695173B1 (fr) 2000-01-26
JPH08510766A (ja) 1996-11-12

Similar Documents

Publication Publication Date Title
AU3269993A (en) An implant
DK0532611T3 (da) Fremgangsmåde til fremstilling af porøse cellulosematrixer
ES8201316A1 (es) Procedimiento de preparar agentes de utilidad clinica a par-tir de substancias solubles en lipoides
DK0695173T3 (da) Fremstilling af matricer
ATE152573T1 (de) Protein mit zeitverabreichung
CA2016297A1 (fr) Dispositif et methode pour la depletion des leucocytes du sang et des composantes du sang
TR27802A (tr) Kendinden dayanikli, gecirgen olacak sekilde gözenekli plastik sekilli gövdeye sahip bir filtre elemani.
BR8404607A (pt) Dispositivo para a liberacao controlada de um material ativo em um meio aquoso e pilula,pastilha,granulo,implante ou bolo alimentar de ruminantes
GR3030706T3 (en) Slow release formulation
DK0912239T3 (da) Fremgangsmåde til tilvejebringelse af komprimerede partikelpræparater til anvendelse ved transdermal partikelafgivelse
ES8707759A1 (es) Un procedimiento para manufacturar un ingrediente antiespumante particulado
CA2205084A1 (fr) Dispositif implantable pour l'administration de substances actives a des vegetaux
UA72988C2 (uk) Керамічний матеріал з високою пористістю у гранульованій формі та спосіб його одержання
JPS57204211A (en) Membrane for purifying mineral oil
JPS5596095A (en) Composite particle group containing active protein substance * production * use and regeneration thereof
JPS52107087A (en) Removal of volatile substance of styrene polymer
JPS5410288A (en) Oxyacid ion adsorbent and adsorbing method
JPS5579011A (en) Separation of oil emulsion
JPS5411080A (en) Separating support
JPS57106610A (en) Preparation of prolonged release type composite
MX9703478A (es) Dispositivo implantable para administrar substancias activas a plantas.
Matje et al. CONTRIBUTION TO THE CONDITIONING OF SIC-SINTER POWDER
JPS51111971A (en) Air filter
JPS5573311A (en) Preparation of filter
HUT56479A (en) Process for producing compositions comprising plant protectives with controlled release of active ingredient and/or plant nourishing materials